Pharmacological Treatment of Deep Vein Thrombosis
Pharmacological Treatment of Deep Vein Thrombosis is organized by Nurse.com - OnCourse Learning Corporation.
Course Originally Released on: 06/27/2023
Date of Most Recent Review: 6/27/2023
Course Termination/ Update Date: 12/31/2026
Description:
When it comes to the treatment of venous thromboembolism (VTE), every member of the healthcare team plays a critical role in ensuring patient safety. Subtherapeutic treatment can lead to blood clots, and the administration of excess dosing may lead to complications of hemorrhage. Keeping up to date with current VTE pharmacotherapy can aid in patients receiving the most optimal treatment for their condition and with providing patient education.
Goal and Learning Outcomes:
The goal of this course is to inform the healthcare team in the acute care setting of the most current information about VTE pharmacological treatment.
After taking this course, you should be able to:
• Recall the American College of Chest Physicians (CHEST) guidelines, duration, and complications of medications used to treat deep vein thrombosis (DVT) and superficial vein thrombosis (SVT).
• Recognize the classes of drugs used to treat DVT and the role of thrombolytics in the management of DVT.
• List the adverse effects of heparin, low-molecular-weight heparin (LMWH), and vitamin K antagonists (VKAs).